Clinical Trial Detail

NCT ID NCT01207492
Title Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Andrew J. Wagner, MD, PhD
Indications

tenosynovial giant cell tumor

Therapies

Nilotinib

Age Groups: adult

No variant requirements are available.